These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 428143)

  • 1. The use of antibody-coated liposomes as a target cell model for antibody-dependent cell-mediated cytotoxicity.
    Geiger B; Schreiber AD
    Clin Exp Immunol; 1979 Jan; 35(1):149-54. PubMed ID: 428143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent cellular cytotoxicity effector cells lack Ia antigens.
    Nelson DL; Sachs DH; Dickler HB
    J Immunol; 1977 Sep; 119(3):1034-40. PubMed ID: 330744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on lymphocyte-mediated cytolysis. XII. Hapten transferred to cell surfaces by interaction with liposomes is recognized by antibody but not by hapten-specific H-2 restricted cytotoxic T cells.
    Ozato K; Henney CS
    J Immunol; 1978 Dec; 121(6):2405-12. PubMed ID: 102694
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary in vitro immunogenicity of liposomal model membranes in mouse spleen cell cultures.
    Yasuda T; Tadakuma T; Pierce CW; Kinsky SC
    J Immunol; 1979 Oct; 123(4):1535-9. PubMed ID: 314464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-dependent cellular cytotoxicity against murine leukemia viral antigens: studies with human lymphoblastoid cell lines and human peripheral lymphocytes as effector cells comparing rabbit, goat, and mouse antisera.
    Peters CJ; Theofilopoulos AN
    J Immunol; 1977 Sep; 119(3):1089-96. PubMed ID: 70469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent cell-mediated cytotoxicity. Comparative ability of murine Peyer's patch and spleen cells to lyse lipopolysaccharide-coated and uncoated erythrocytes.
    Kagnoff MF; Campbell S
    Gastroenterology; 1976 Mar; 70(3):341-6. PubMed ID: 1082425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biologic activity of affinity cross-linked oligomers of rabbit immunogloblin G as tested by antigody-dependent cell-mediated cytolysis (ADCC).
    Hurwitz E; Zatz MM; Segal DM
    J Immunol; 1977 Apr; 118(4):1348-53. PubMed ID: 850066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes as model membrane systems for immune attack. I. Transfer of antigenic determinants to lymphocyte membranes after interactions with hapten-bearing liposomes.
    Ozato K; Ziegler HK; Henney CS
    J Immunol; 1978 Oct; 121(4):1376-82. PubMed ID: 81230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
    Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
    J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
    Cordier G; Samarut C; Revillard JP
    Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
    Warnatz H; Rösch W; Gerlich W; Gutmann W
    Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging.
    Jondal M
    Clin Exp Immunol; 1977 Jul; 29(1):1-10. PubMed ID: 196801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. II. The mouse nonadherent K cell.
    Greenberg AH; Shen L; Walker L; Arnaiz-Villena A; Roitt IM
    Eur J Immunol; 1976 Jul; 5(7):474-80. PubMed ID: 976311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate receptor-mediated cellular cytotoxicity. A method for "custom designing" killer cells of desired target specificity.
    Colsky AS; Stein-Streilein J; Peacock JS
    J Immunol; 1988 Apr; 140(8):2515-9. PubMed ID: 3258612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
    J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of K lymphocytes with myeloma proteins of different IgG subclasses.
    Spiegelberg HL; Perlmann H; Perlmann P
    J Immunol; 1976 Nov; 117(5 Pt 1):1464-71. PubMed ID: 1002986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
    Christiaansen JE; Burnside SS; Sears DW
    J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
    Saxena RK; Saxena QB; Adler WH
    Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations of IgG1 anti-DNP hybridoma-mediated ADCC and the failure of three IgM anti-DNP hybridomas to mediate ADCC.
    Greenberg AH; Lydyard PM
    J Immunol; 1979 Aug; 123(2):861-9. PubMed ID: 458155
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific stimulation and suppression of a primary in vitro plaque-forming cell response by monovalent lipid haptens in fluid liposomal membranes.
    Humphries GM
    J Immunol; 1979 Nov; 123(5):2126-32. PubMed ID: 573772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.